Clinical Performance of an Alkasite-based Restorative Material
NCT ID: NCT06317857
Last Updated: 2024-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
68 participants
INTERVENTIONAL
2024-04-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of An Alkasite Based Restorative Material With And Without Adhesive
NCT06273410
Clinical Evaluation of Bioactive Resin Composites Versus Caries Control Technique in Management of Class I Carious Cavities in High Caries Risk Patients: a Randomized Clinical Trial
NCT06797843
Clinical Performance of Novel Alkasite Restorative Material "Cention Forte" in Class II Restorations
NCT06833528
Three-Year Clinical Performance of Fiber-reinforced Versus Indirect Resin Composite Posterior Restorations
NCT06803537
Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult With Class V Carious
NCT04716517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For decades, dentists have been looking for a material that is affordable, fluoride releasing, easy to apply, strong, and aesthetically pleasing. A novel bioactive, alkasite material has been introduced enabling quick and efficient minimally invasive treatment. . It is a self-curing radiopaque material for direct treatment of anterior and posterior cavities. It is claimed as a tooth coloured, bioactive, durable material to be rendered as the new alternative to amalgam for permanent Class I and II restorations. It also promotes remineralization and prevents demineralization with an advanced ion-releasing system. When the pH drops because of the growth of the cariogenic bacteria, it releases hydroxide ions to help restore the pH balance. Hydroxide ions help to prevent tooth structure from being demineralized. The fluoride and calcium ions released help remineralize the tooth structure and prevent secondary caries.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Centio Forte (Ivoclar).
A new class of bioactive "alkasite" restorative materials has been released in the market. They're composed of three main filler types: salinized inert barium aluminium silicate glass, calcium barium aluminium fluorosilicate glass similar to glass-ionomers, and calcium fluorosilicate glass or "alkasite" glass. Cention N (Ivoclar Vivadent) was the first available material in the material in the form of powder/liquid, later on, Cention forte was released which is the modified capsulated form with a special adhesive system Marovic et al. (2022).
Cention has the ability to remineralize hard dental tissues through calcium and fluoride release and can also neutralize bacterial acids through hydroxide ions release Par et al. (2020).
Centio Forte
A new Alkasite material has been introduced with superior strength and bioactive ion release where it is considered the new alternative to amalgam.
Highly viscous glass ionomer
Glass-ionomer restorations (GI) are widely used in restorative dentistry. One of their advantages is their chemical adhesion to tooth structure. They also possess a fluoride-releasing property and biocompatibility. Although GIs are commonly used, they have some disadvantages. The most intractable problem with the conventional GIs is probably their lack of strength and toughness. In order to improve the mechanical properties of conventional GICs, reinforced GIs were developed. These reinforced GIs or now commonly known as highly viscous GIs provide improved mechanical properties and wear resistance, easier application allowing their use in posterior stress bearing cavity preparations Bakhadher et al.
(2019).
Centio Forte
A new Alkasite material has been introduced with superior strength and bioactive ion release where it is considered the new alternative to amalgam.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Centio Forte
A new Alkasite material has been introduced with superior strength and bioactive ion release where it is considered the new alternative to amalgam.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with at least 20 teeth under occlusion.
* Age: 16-55 years.
* Co-operative patients approving to participate in the trial.
Exclusion Criteria
* Extensive occlusal lesions.
* Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
* Teeth supporting removable prostheses, or orthodontic appliances.
* Candidates with parafunction or bruxism.
* Candidates with systemic diseases or disabilities that may affect participation.
* Drug-induced xerostomia.
* Heavy smoking.
* Pregnancy.
* Lack of compliance.
16 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tarek Mohamed Tawfik Alagamawy
Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14422021443228
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.